DUBLIN, Feb. 12, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/wcrtxc/fertility_market) has announced the addition of the "Fertility Market in the US 2016-2020" report to their offering.
The fertility services market in the US is expected to grow at a CAGR of 4.07% during the period 2016-2020.
Vendors undergo M&A to expand their geographical presence, enhance their product portfolio, and attain profit margins. M&A allows vendors to gain proprietary technologies and innovative products of the acquired company. Small vendors undergo M&A to broaden their network and expand people's access to their new products.
According to the report, the fertility market in the US consists of fertility drugs and assisted reproductive technology (ART) services segments. Increasing fertility issues among the aging population, rising disposable income, growing adoption of fertility services by homosexual couples, and augmented support from the US federal government are some of the major factors that will impel growth in this market during the forecast period.
Further, the report states that high cost of fertility treatment hinders the market growth.
Key questions answered in this report:
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
- Ferring Pharmaceuticals
Other prominent vendors:
- Abbott Laboratories
- Apricus Biosciences
- Bristol-Myers Squibb
- Elelixis Diagnostics
- Eli Lilly
- EMD Serono
- IKS International
- In Vitro Care
- Invo Bioscience
- Irvine Scientific
- IVFtech Aps
- Life Global
- Medical Electronic Systems
- Pantec Biosolutions
- Xytex Cryo International
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Regulatory scenario in the US
PART 06: Market landscape
PART 07: Infertility: An overview
PART 08: Stages of fertility treatment
PART 09: Cost analysis of ART
PART 10: Market segmentation by type
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
For more information visit http://www.researchandmarkets.com/research/wcrtxc/fertility_market
Laura Wood , +353-1-481-1716, firstname.lastname@example.org